Alternate day and daily administration of GnRH antagonist may prevent premature luteinization to a similar extent during FSH treatment

Abstract

Whether alternate day is as effective as daily administration of ganirelix in preventing premature luteinization should be addressed in a non-inferiority trial powered to evaluate live birth rate.